Ware Norma C, Idoko John, Kaaya Sylvia, Biraro Irene Andia, Wyatt Monique A, Agbaji Oche, Chalamilla Guerino, Bangsberg David R
Harvard Medical School, Boston, Massachusetts, United States of America.
PLoS Med. 2009 Jan 27;6(1):e11. doi: 10.1371/journal.pmed.1000011.
Individuals living with HIV/AIDS in sub-Saharan Africa generally take more than 90% of prescribed doses of antiretroviral therapy (ART). This number exceeds the levels of adherence observed in North America and dispels early scale-up concerns that adherence would be inadequate in settings of extreme poverty. This paper offers an explanation and theoretical model of ART adherence success based on the results of an ethnographic study in three sub-Saharan African countries.
Determinants of ART adherence for HIV-infected persons in sub-Saharan Africa were examined with ethnographic research methods. 414 in-person interviews were carried out with 252 persons taking ART, their treatment partners, and health care professionals at HIV treatment sites in Jos, Nigeria; Dar es Salaam, Tanzania; and Mbarara, Uganda. 136 field observations of clinic activities were also conducted. Data were examined using category construction and interpretive approaches to analysis. Findings indicate that individuals taking ART routinely overcome economic obstacles to ART adherence through a number of deliberate strategies aimed at prioritizing adherence: borrowing and "begging" transport funds, making "impossible choices" to allocate resources in favor of treatment, and "doing without." Prioritization of adherence is accomplished through resources and help made available by treatment partners, other family members and friends, and health care providers. Helpers expect adherence and make their expectations known, creating a responsibility on the part of patients to adhere. Patients adhere to promote good will on the part of helpers, thereby ensuring help will be available when future needs arise.
Adherence success in sub-Saharan Africa can be explained as a means of fulfilling social responsibilities and thus preserving social capital in essential relationships.
撒哈拉以南非洲地区感染艾滋病毒/艾滋病的人通常服用超过90%的规定抗逆转录病毒疗法(ART)剂量。这一数字超过了在北美观察到的依从水平,并消除了早期扩大治疗规模时人们对在极端贫困环境中依从性不足的担忧。本文基于在三个撒哈拉以南非洲国家进行的人种学研究结果,提供了一个关于抗逆转录病毒疗法依从性成功的解释和理论模型。
采用人种学研究方法,对撒哈拉以南非洲地区艾滋病毒感染者的抗逆转录病毒疗法依从性决定因素进行了研究。在尼日利亚乔斯、坦桑尼亚达累斯萨拉姆和乌干达姆巴拉拉的艾滋病毒治疗点,对252名接受抗逆转录病毒疗法的患者、他们的治疗伙伴和医护人员进行了414次面对面访谈。还对诊所活动进行了136次实地观察。使用类别构建和解释性分析方法对数据进行了检查。研究结果表明,接受抗逆转录病毒疗法的个体通过一系列旨在优先考虑依从性的刻意策略,常规性地克服了抗逆转录病毒疗法依从性方面的经济障碍:借贷和“乞讨”交通费用、做出“不可能的选择”以分配资源支持治疗以及“省吃俭用”。依从性的优先排序是通过治疗伙伴、其他家庭成员和朋友以及医护人员提供的资源和帮助来实现的。帮助者期望患者依从并表明他们的期望,这使得患者有责任依从。患者依从以促进帮助者的善意,从而确保在未来有需要时能得到帮助。
撒哈拉以南非洲地区的依从性成功可以解释为履行社会责任的一种方式,从而在重要关系中保留社会资本。